ストックスクリーナーアプリを入手
0.3574
2.55%
0.0089
前日終値:
$0.3485
開ける：
$0.342
24時間の取引高:
54,058
Relative Volume:
0.52
時価総額：
$3.84M
収益：
当期純損益:
$-3.28M
株価収益率:
-0.3435
EPS:
-1.0406
ネットキャッシュフロー:
$-4.80M
1週間 パフォーマンス:
-10.07%
1か月 パフォーマンス:
-6.51%
6か月 パフォーマンス:
-53.07%
1年 パフォーマンス:
-64.61%
1日の値動き範囲:
$0.342
$0.3624
1週間の範囲:
$0.3401
$0.4149
52週間の値動き範囲:
$0.3339
$1.51
Pharmacyte Biotech Inc Stock (PMCB) Company Profile
名前
Pharmacyte Biotech Inc
セクター
電話
(917) 595.2850
住所
3960 HOWARD HUGHES PARKWAY, LAS VEGAS
Compare PMCB vs VRTX, MRNA, REGN, ARGX, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
PMCB
Pharmacyte Biotech Inc
|
0.3574 | 3.84M | 0 | -3.28M | -4.80M | -1.0406 |
VRTX
Vertex Pharmaceuticals Inc
|
508.75 | 128.95B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
236.50 | 94.42B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
796.34 | 81.99B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
846.27 | 53.22B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
374.08 | 42.32B | 5.76B | 514.49M | 1.10B | 4.4813 |
Pharmacyte Biotech Inc (PMCB) 最新ニュース
Is PharmaCyte Biotech (NASDAQ:PMCB) Stock Worth Watching Today? - kalkinemedia.com
Could PharmaCyte Biotech (NASDAQ:PMCB) Shift the Penny Stocks Story? - kalkinemedia.com
PharmaCyte (NASDAQ: PMCB) risks delisting if its stock stays below $1 - Stock Titan
PharmaCyte Biotech Inc (PMCB) Key Financial Ratios – Valuation, Profitability & More - Value Research
PharmaCyte Biotech Inc (PMCB) Financials – Balance Sheet, Profit & Loss, Cash Flow - valueresearchonline.com
PharmaCyte Biotech Inc (PMCB) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
PharmaCyte Biotech (NASDAQ: PMCB): Why Is A scheduled reporting event in Focus Now? - Kalkine Media
PMCBPharmaCyte Biotech Inc Forecast, Target Price - Finviz
PharmaCyte (PMCB) Financial Results: The Company Lists Its Latest Available Figures in the Current Update; Market Reaction: Shares Move 1.58% HigherQuarterly Profit Report - vinanet.vn
PharmaCyte (PMCB) Share-Price Review: Slides 4.80% to $0.52 at the Close; Technical Focus: Price Remains Between $0.49 Support and $0.55 Resistance in the Current UpdateEarnings Miss Risk - vinanet.vn
PMCB Q1 2026 Earnings: Clinical-Stage Biotech Posts -$0.09 EPS with No RevenueSegment Revenue Breakdown - vinanet.vn
PharmaCyte Biotech (PMCB) Climbs to $0.55 as Micro-Cap Biotech Holds Key SupportFundamentals - dars.gov.et
PharmaCyte Biotech (PMCB) Climbs to $0.55 as Micro-Cap Biotech Holds Key SupportEarnings Breakout Stocks - vinanet.vn
PharmaCyte Biotech Inc (PMCB) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
PharmaCyte Biotech Inc (PMCB) Stock News Today - TradingKey
PharmaCyte Biotech (PMCB) Holds Near $0.59 as Shares Dip 0.71%Change of Character - vinanet.vn
PharmaCyte Biotech (PMCB) Q1 2026 Earnings: Narrowing Loss Amid Clinical ProgressHealthcare Earnings Report - dars.gov.et
PharmaCyte Biotech, Inc. FY 2026: Revenue $0 Net income ($23.21M), EPS ($2.77) — 10-K Summary - TradingView
PharmaCyte Biotech Inc (PMCB) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
PharmaCyte Biotech Inc (PMCB) Institutional Confidence - TradingKey
PharmaCyte Biotech Inc (PMCB) Shareholder Structure: Major Shareholders & Institutional Holdings - tradingkey.com
PharmaCyte Biotech Inc (PMCB) Balance Sheet - TradingKey
PharmaCyte Biotech Inc (PMCB) Cash Flow - TradingKey
PharmaCyte Biotech Inc (PMCB) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
PharmaCyte Biotech Inc (PMCB) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
PMCB|PharmaCyte Biotech Inc|Price:0.600|Chg%:-0.005 - TradingKey
PharmaCyte Biotech Inc (PMCB) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
PharmaCyte Biotech Inc (PMCB) Valuation: PE, PB & Fair Value Analysis - TradingKey
PharmaCyte Biotech Inc (PMCB) Income Statement - TradingKey
PMCB|PharmaCyte Biotech Inc|Price:0.576|Chg%:-0.024 - tradingkey.com
PMCB|PharmaCyte Biotech Inc|Price:0.611|Chg%:+0.035 - TradingKey
PharmaCyte Biotech (PMCB) Holds Near $0.57 Support Amid Minimal Price MovementSMA Signal - vinanet.vn
PharmaCyte Biotech Inc. (PMCB) Q1 2026 Earnings: Revenue-less Biotech Posts Net Loss; Stock SlipsEarnings Revision Report - vinanet.vn
PharmaCyte Biotech, Inc. Revenue Breakdown – NASDAQ:PMCB - TradingView
PharmaCyte Biotech Inc (PMCB) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
PharmaCyte Biotech (PMCB) Edges Lower Near Support; Key Levels in FocusLong Short Pair - vinanet.vn
PMCB Q1 2026 Earnings: Continued Development Costs Weigh on Results, No Revenue ReportedEarnings Season Outlook - vinanet.vn
PharmaCyte Biotech (PMCB) Slips 4% as Stock Tests Key Support Near $0.60Andrews Pitchfork - dars.gov.et
PharmaCyte Biotech (PMCB) Slips 4% as Stock Tests Key Support Near $0.60Island Reversal - careplusvn.com
PharmaCyte Biotech | 4: Statement of changes in beneficial ownership of securities-Director SCHECHTER JONATHAN - Moomoo
PharmaCyte Biotech (PMCB) Faces Near-Term Pressure, Testing Key Support at $0.60Tick Index - vinanet.vn
[Form 4/A] PharmaCyte Biotech, Inc. Amended Insider Trading Activity - Stock Titan
PharmaCyte Biotech (PMCB) cancels erroneous stock option grant - Stock Titan
PharmaCyte Biotech (PMCB) amends Form 4 to cancel option grant - Stock Titan
PharmaCyte Biotech (PMCB) director corrects erroneous, cancelled option grant - Stock Titan
PharmaCyte Biotech (PMCB) Slides 6.6% as Biotech Selling Pressure PersistsDebt Free Companies - dars.gov.et
PharmaCyte Biotech (PMCB) Slides 6.6% as Biotech Selling Pressure PersistsBox Spread - dars.gov.et
PharmaCyte Biotech (PMCB) Slides 6.6% as Biotech Selling Pressure PersistsIceberg Order - vinanet.vn
PharmaCyte Biotech (PMCB) Slides 1.4% Near Key Support Level at $0.66Adaptive Moving Average - dars.gov.et
PharmaCyte Biotech (PMCB) Holds Near Support as Modest Decline Tests Trader ConvictionGap Down Bounce Plays - dars.gov.et
Pharmacyte Biotech Inc (PMCB) 財務データ
収益
当期純利益
現金流量
EPS
Pharmacyte Biotech Inc (PMCB) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| SCHECHTER JONATHAN | Director |
Jan 07 '26 |
Buy |
0.84 |
20,000 |
16,872 |
192,500 |
| Silverman Joshua | CEO and President |
Jan 06 '26 |
Buy |
0.79 |
30,000 |
23,667 |
376,250 |
| SCHECHTER JONATHAN | Director |
Jan 06 '26 |
Buy |
0.79 |
20,000 |
15,808 |
172,500 |
| Silverman Joshua | CEO and President |
Jan 05 '26 |
Buy |
0.78 |
30,000 |
23,493 |
346,250 |
| SCHECHTER JONATHAN | Director |
Jan 05 '26 |
Buy |
0.78 |
20,000 |
15,552 |
152,500 |
1.35%
大文字化:
|
ボリューム (24 時間):